Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001214659-23-016101

Director acquired 952 shares (code L)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Jones James Director 2023-11-01 Other acquisition 10b5-1 +55 $1.85 $102 30,336 D
Jones James Director 2023-11-02 Other acquisition 10b5-1 +55 $1.97 $108 30,391 D
Jones James Director 2023-11-03 Other acquisition 10b5-1 +55 $2.06 $113 30,446 D
Jones James Director 2023-11-06 Other acquisition 10b5-1 +55 $2.03 $112 30,501 D
Jones James Director 2023-11-07 Other acquisition 10b5-1 +19 $2.01 $38 30,520 D
Jones James Director 2023-11-08 Other acquisition 10b5-1 +55 $2.00 $110 30,575 D
Jones James Director 2023-11-09 Other acquisition 10b5-1 +55 $1.82 $100 30,630 D
Jones James Director 2023-11-10 Other acquisition 10b5-1 +55 $1.77 $97 30,685 D
Jones James Director 2023-11-13 Other acquisition 10b5-1 +46 $1.75 $81 30,731 D
Jones James Director 2023-11-14 Other acquisition 10b5-1 +55 $1.73 $95 30,786 D
Jones James Director 2023-11-15 Other acquisition 10b5-1 +55 $1.78 $98 30,841 D
Jones James Director 2023-11-16 Other acquisition 10b5-1 +13 $1.73 $22 30,854 D
Jones James Director 2023-11-17 Other acquisition 10b5-1 +55 $1.83 $101 30,909 D
Jones James Director 2023-11-20 Other acquisition 10b5-1 +53 $1.70 $90 30,962 D
Jones James Director 2023-11-21 Other acquisition 10b5-1 +25 $1.76 $44 30,987 D
Jones James Director 2023-11-22 Other acquisition 10b5-1 +55 $1.74 $96 31,042 D
Jones James Director 2023-11-27 Other acquisition 10b5-1 +72 $1.86 $134 31,114 D
Jones James Director 2023-11-28 Other acquisition 10b5-1 +25 $1.68 $42 31,139 D
Jones James Director 2023-11-29 Other acquisition 10b5-1 +32 $1.73 $55 31,171 D
Jones James Director 2023-11-30 Other acquisition 10b5-1 +62 $1.66 $103 31,233 D
Loading xslF345X05/marketforms-63725.xml…